DE60004961D1 - Analytisches Verfahren zur Beurteilung von nicht-humanen Tiermodellen für neurofibrilläre Degenerationserkrankungen - Google Patents

Analytisches Verfahren zur Beurteilung von nicht-humanen Tiermodellen für neurofibrilläre Degenerationserkrankungen

Info

Publication number
DE60004961D1
DE60004961D1 DE60004961T DE60004961T DE60004961D1 DE 60004961 D1 DE60004961 D1 DE 60004961D1 DE 60004961 T DE60004961 T DE 60004961T DE 60004961 T DE60004961 T DE 60004961T DE 60004961 D1 DE60004961 D1 DE 60004961D1
Authority
DE
Germany
Prior art keywords
assessment
animal models
human animal
analytical procedure
neurofibrillary degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60004961T
Other languages
English (en)
Other versions
DE60004961T2 (de
Inventor
Dr Roder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nad AG
Original Assignee
Nad AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nad AG filed Critical Nad AG
Publication of DE60004961D1 publication Critical patent/DE60004961D1/de
Application granted granted Critical
Publication of DE60004961T2 publication Critical patent/DE60004961T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE60004961T 2000-02-02 2000-02-02 Analytisches Verfahren zur Bewertung von Tiermodellen der neurofibrillären Degeneration Expired - Fee Related DE60004961T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00102057A EP1126279B1 (de) 2000-02-02 2000-02-02 Analytisches Verfahren zur Beurteilung von nicht-humanen Tiermodellen für neurofibrilläre Degenerationserkrankungen

Publications (2)

Publication Number Publication Date
DE60004961D1 true DE60004961D1 (de) 2003-10-09
DE60004961T2 DE60004961T2 (de) 2004-07-29

Family

ID=8167755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004961T Expired - Fee Related DE60004961T2 (de) 2000-02-02 2000-02-02 Analytisches Verfahren zur Bewertung von Tiermodellen der neurofibrillären Degeneration

Country Status (10)

Country Link
US (1) US20030133874A1 (de)
EP (1) EP1126279B1 (de)
JP (1) JP2003521713A (de)
AT (1) ATE249048T1 (de)
AU (1) AU777983B2 (de)
CA (1) CA2399121A1 (de)
DE (1) DE60004961T2 (de)
DK (1) DK1126279T3 (de)
ES (1) ES2204368T3 (de)
WO (1) WO2001057535A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477604A1 (en) * 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
WO2005080986A1 (en) * 2004-02-18 2005-09-01 University Of Iowa Research Foundation Antibodies to phosphorylated tau, methods of making and methods of use
US20070280935A1 (en) * 2006-04-07 2007-12-06 Bernd Bohrmann Antibody that recognizes phosphorylated peptides
EP1876185A1 (de) * 2006-07-04 2008-01-09 F. Hoffmann-La Roche Ag Antikörper, der phosphorylierte Polypeptide erkennt
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
CN113244402B (zh) * 2021-05-27 2022-11-18 山西医科大学 P-ERK信号通路在抑制铝导致的tau蛋白异常磷酸化和细胞毒性中的应用
CN113462722A (zh) * 2021-06-24 2021-10-01 南通大学 通过腺相关病毒介导的抑制tau病理朊样传播的方法

Also Published As

Publication number Publication date
WO2001057535A3 (en) 2002-02-21
US20030133874A1 (en) 2003-07-17
DK1126279T3 (da) 2003-11-17
JP2003521713A (ja) 2003-07-15
WO2001057535A2 (en) 2001-08-09
EP1126279A1 (de) 2001-08-22
DE60004961T2 (de) 2004-07-29
AU777983B2 (en) 2004-11-11
AU3923601A (en) 2001-08-14
EP1126279B1 (de) 2003-09-03
ATE249048T1 (de) 2003-09-15
ES2204368T3 (es) 2004-05-01
CA2399121A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
ATE386942T1 (de) Verfahren zur voraussage, zur diagnose und zur vergleichenden diagnose von alzheimer
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
DK2211183T3 (da) Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom
DE60117008D1 (de) Giessform und verfahren zur herstellung von ophthalmischen linsen
ATE527276T1 (de) Proteine, die veränderte immunogene reaktionen bewirken, und verfahren zu deren herstellung und anwendung
WO2005080594A3 (en) Method for determining the risk of developing a neurological disease
ATE316860T1 (de) Verfahren zur automatischen herstellung von brillenlinsen
DE602004016508D1 (de) Kautschukbahn und verfahren zur herstellung von kernmetall für kautschukbahn
ATE300052T1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
DE10081270D2 (de) Verfahren zur prozessgesteuerten und kundenindividuellen Herstellung eines Gegenstandes
ATA11042002A (de) Verfahren zur simulation des fahrverhaltens von fahrzeugen
DE60004961D1 (de) Analytisches Verfahren zur Beurteilung von nicht-humanen Tiermodellen für neurofibrilläre Degenerationserkrankungen
DE10295664D2 (de) Verfahren zum Nachweis von Morbus Alzheimer und zur Unterscheidung von Morbus Alzheimer gegenüber anderen demenziellen Erkrankungen, zugehörige Paptide und deren Verwendungen
ATE433441T1 (de) Verfahren und vorrichtung zur herstellung von percarbonsäure
DE602004025267D1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
DE60221018D1 (de) Verfahren und vorrichtung zur herstellung von kontaktlinsen
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
DE60303410D1 (de) Verfahren und Vorrichtung zur Herstellung von Tonern für Elektrofotografie
ATE465408T1 (de) Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins
DE60216570D1 (de) Verfahren zum nachweis von alzheimer-krankheit
DE60308066D1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
ATE301634T1 (de) Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden
DE60316541D1 (de) Keimextrakt zur zellfreien proteinsynthese und verfahren zu dessen herstellung
WO2003074558A3 (en) Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
DE60306992D1 (de) Verfahren zur Herstellung von Intraokularlinsen und so hergestellte Intraokularlinse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee